In Vivo RNA Delivery to Hematopoietic Stem and Progenitor Cells via Targeted Lipid Nanoparticles

D Shi, S Toyonaga, DG Anderson - Nano Letters, 2023 - ACS Publications
Ex vivo autologous hematopoietic stem cell (HSC) gene therapy has provided new therapies
for the treatment of hematological disorders. However, these therapies have several …
被引用次数：46 相关文章

In Vivo RNA Delivery to Hematopoietic Stem and Progenitor Cells via Targeted Lipid Nanoparticles

D Shi, S Toyonaga, DG Anderson - Nano letters, 2023 - pubmed.ncbi.nlm.nih.gov
Ex vivo autologous hematopoietic stem cell (HSC) gene therapy has provided new therapies
for the treatment of hematological disorders. However, these therapies have several …

In Vivo RNA Delivery to Hematopoietic Stem and Progenitor Cells via Targeted Lipid Nanoparticles.

D Shi, S Toyonaga, DG Anderson - Nano Letters, 2023 - europepmc.org
Ex vivo autologous hematopoietic stem cell (HSC) gene therapy has provided new therapies
for the treatment of hematological disorders. However, these therapies have several …
[HTML] nih.gov

[HTML][HTML] In Vivo RNA Delivery to Hematopoietic Stem and Progenitor Cells via Targeted Lipid Nanoparticles

D Shi, S Toyonaga, DG Anderson - Nano Letters, 2023 - ncbi.nlm.nih.gov
Ex vivo autologous hematopoietic stem cell (HSC) gene therapy has provided new therapies
for the treatment of hematological disorders. However, these therapies have several …

[引用][C] In Vivo RNA Delivery to Hematopoietic Stem and Progenitor Cells via Targeted Lipid Nanoparticles

D Shi, S Toyonaga, DG Anderson - Nano Letters, 2023 - ui.adsabs.harvard.edu
In Vivo RNA Delivery to Hematopoietic Stem and Progenitor Cells via Targeted Lipid
Nanoparticles - NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS …